{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T01:01:55Z","timestamp":1793581315888,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.brachy.2018.09.006","type":"journal-article","created":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T18:46:59Z","timestamp":1540838819000},"page":"63-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Treatment of metastatic, imatinib refractory, gastrointestinal stroma tumor with image-guided high-dose-rate interstitial brachytherapy"],"prefix":"10.1016","volume":"18","author":[{"given":"Jazan","family":"Omari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Drewes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manig","family":"Matthias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Mohnike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Seidensticker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricarda","family":"Seidensticker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Streitparth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Ricke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Powerski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Pech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2018.09.006_bib1","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1470-2045(02)00899-9","article-title":"Management of malignant gastrointestinal stromal tumours","volume":"3","author":"Joensuu","year":"2002","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2018.09.006_bib2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jvir.2012.11.021","article-title":"Radiofrequency ablation for liver metastasis from gastrointestinal stromal tumor","volume":"24","author":"Yamanaka","year":"2013","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.brachy.2018.09.006_bib3","first-page":"31","article-title":"Gastrointestinal stromal tumours: outcomes of surgical management and analysis of prognostic variables","volume":"52","author":"Unalp","year":"2009","journal-title":"Can J Surg"},{"key":"10.1016\/j.brachy.2018.09.006_bib4","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1200\/JCO.2005.14.068","article-title":"PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in\u00a0vitro sensitivity to imatinib","volume":"23","author":"Corless","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2018.09.006_bib5","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0140-6736(04)17098-0","article-title":"Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial","volume":"364","author":"Verweij","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2018.09.006_bib6","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1245\/s10434-013-3279-9","article-title":"The effects of surgical cytoreduction prior to imatinib therapy on the prognosis of patients with advanced GIST","volume":"20","author":"An","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.brachy.2018.09.006_bib7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.6004\/jnccn.2018.0025","article-title":"Soft tissue sarcoma, version 2.2018, NCCN clinical practice guidelines in oncology","volume":"16","author":"von Mehren","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.brachy.2018.09.006_bib8","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1053\/hupa.2002.124122","article-title":"Clinical management of gastrointestinal stromal tumors: before and after STI-571","volume":"33","author":"Dematteo","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1016\/j.brachy.2018.09.006_bib9","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1471-2407-12-90","article-title":"Survival of gastrointestinal stromal tumor patients in the imatinib era: life raft group observational registry","volume":"12","author":"Call","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.brachy.2018.09.006_bib10","doi-asserted-by":"crossref","first-page":"e8240","DOI":"10.1097\/MD.0000000000008240","article-title":"Gastrointestinal stromal tumor (GIST) with liver metastases: an 18-year experience from the GIST cooperation group in North China","volume":"96","author":"Shi","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.brachy.2018.09.006_bib11","doi-asserted-by":"crossref","first-page":"9024","DOI":"10.1200\/jco.2004.22.90140.9024","article-title":"Safety and efficacy of percutaneous radio-frequency ablation (RFA) in patients (pts) with metastatic gastrointestinal stromal tumor (GIST) with clonal evolution of lesions refractory to imatinib mesylate (IM)","volume":"22","author":"Dileo","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2018.09.006_bib12","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ejso.2009.12.005","article-title":"Radiofrequency ablation is a feasible therapeutic option in the multi modality management of sarcoma","volume":"36","author":"Jones","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.brachy.2018.09.006_bib13","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/01.RVI.0000141343.43441.06","article-title":"Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation","volume":"15","author":"Ricke","year":"2004","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.brachy.2018.09.006_bib14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1748-717X-6-107","article-title":"In\u00a0vivo assessment of catheter positioning accuracy and prolonged irradiation time on liver tolerance dose after single-fraction 192Ir high-dose-rate brachytherapy","volume":"6","author":"L\u00fcdemann","year":"2011","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.brachy.2018.09.006_bib15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1109\/4233.681165","article-title":"CT-based software for 3-D localization and reconstruction in stepping source brachytherapy","volume":"1","author":"Tsalpatouros","year":"1997","journal-title":"IEEE Trans Inf Technol Biomed"},{"key":"10.1016\/j.brachy.2018.09.006_bib16","first-page":"2597","article-title":"CT-guided high-dose-rate brachytherapy of metachronous ovarian cancer metastasis to the liver: initial experience","volume":"31","author":"Collettini","year":"2011","journal-title":"Anticancer Res"},{"key":"10.1016\/j.brachy.2018.09.006_bib17","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.ijrobp.2006.02.052","article-title":"In\u00a0vivo assessment of the gastric mucosal tolerance dose after single fraction, small volume irradiation of liver malignancies by computed tomography-guided, high-dose-rate brachytherapy","volume":"65","author":"Streitparth","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2018.09.006_bib18","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.jvir.2014.08.027","article-title":"Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update","volume":"25","author":"Ahmed","year":"2014","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.brachy.2018.09.006_bib19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3348\/kjr.2018.19.1.54","article-title":"Ultrasound-guided intraoperative radiofrequency ablation and surgical resection for liver metastasis from malignant gastrointestinal stromal tumors","volume":"19","author":"Yoon","year":"2018","journal-title":"Korean J Radiol"},{"issue":"Suppl 4","key":"10.1016\/j.brachy.2018.09.006_bib20","doi-asserted-by":"crossref","first-page":"iv68","DOI":"10.1093\/annonc\/mdy095","article-title":"Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Casali","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.brachy.2018.09.006_bib21","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1200\/JCO.2005.05.3439","article-title":"Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors","volume":"24","author":"Raut","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2018.09.006_bib22","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ejso.2013.12.020","article-title":"Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib -- analysis of prognostic factors (EORTC-STBSG collaborative study)","volume":"40","author":"Bauer","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.brachy.2018.09.006_bib23","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s00595-009-4171-x","article-title":"Resection combined with imatinib therapy for liver metastases of gastrointestinal stromal tumors","volume":"40","author":"Xia","year":"2010","journal-title":"Surg Today"},{"key":"10.1016\/j.brachy.2018.09.006_bib24","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1001\/archsurg.141.6.537","article-title":"Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver","volume":"141","author":"Pawlik","year":"2006","journal-title":"Arch Surg"},{"key":"10.1016\/j.brachy.2018.09.006_bib25","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(06)69446-4","article-title":"Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial","volume":"368","author":"Demetri","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2018.09.006_bib26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.5114\/jcb.2016.61068","article-title":"Image-guided high-dose-rate brachytherapy of malignancies in various inner organs - technique, indications, and perspectives","volume":"8","author":"Bretschneider","year":"2016","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2018.09.006_bib27","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s00066-017-1120-2","article-title":"Radioablation of adrenal gland malignomas with interstitial high-dose-rate brachytherapy\u202f: efficacy and outcome","volume":"193","author":"Mohnike","year":"2017","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.brachy.2018.09.006_bib28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijsu.2017.01.045","article-title":"Surgical management of patients with progressing metastatic gastrointestinal stromal tumors receiving sunitinib treatment: a prospective cohort study","volume":"39","author":"Yeh","year":"2017","journal-title":"Int J Surg"},{"key":"10.1016\/j.brachy.2018.09.006_bib29","doi-asserted-by":"crossref","first-page":"iii21","DOI":"10.1093\/annonc\/mdu255","article-title":"Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"25","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.brachy.2018.09.006_bib30","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejca.2016.05.019","article-title":"Indications for surgery in advanced\/metastatic GIST","volume":"63","author":"Ford","year":"2016","journal-title":"Eur J Cancer"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472118305403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472118305403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:14:01Z","timestamp":1761531241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472118305403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1538472118305403"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2018.09.006","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of metastatic, imatinib refractory, gastrointestinal stroma tumor with image-guided high-dose-rate interstitial brachytherapy","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2018.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}